FDA’s final rule impact on direct-to-consumer prescription drug ads
The FDA’s final rule for Direct-to-Consumer (DTC) Prescription Drug Advertisements became effective on May 20, implementing the statutory requirement that DTC advertisements for prescription drugs (Rx) in television or radio format must present the “major statement” on the drug’s most important risks, in a “clear, conspicuous, and neutral” manner.